Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-010233
Filing Date
2017-07-07
Accepted
2017-07-07 20:01:46
Documents
1
Period of Report
2017-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1695
  Complete submission text file 0001179110-17-010233.txt   3260
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP. 1 KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139
Business Address
Toselli Richard M. (Reporting) CIK: 0001710549 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37350 | Film No.: 17956134